Finance

Lists
307280:KOSDAQ
Wonbiogen Co Ltd
₩5,490.00
+2.23%
(+120.00) 1D
Jul 24, 3:30:30 PM GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 307280...
Open
₩5,500
High
₩5,570
Low
₩5,350
Mkt. cap
38.95B
Avg. vol.
19.75K
Volume
15.05K
Dividend
2.55%
Quarterly dividend
₩35
Ex-dividend date
Dec 27, 2024
P/E ratio
5.50
52-wk high
₩8,400
52-wk low
₩4,765
EPS
₩999
Shares outstanding
7.09M
No. of employees
79
Open
₩5,500
High
₩5,570
Low
₩5,350
Mkt. cap
38.95B
Avg. vol.
19.75K
Volume
15.05K
Dividend
2.55%
Quarterly dividend
₩35
Ex-dividend date
Dec 27, 2024
P/E ratio
5.50
52-wk high
₩8,400
52-wk low
₩4,765
EPS
₩999
Shares outstanding
7.09M
No. of employees
79
News stories
From sources across the web
About Wonbiogen Co Ltd
CEO-
Employees79
Founded2006
Headquarters-
SectorMedical device
Websitewonbiogen.co.kr
Previous reportsAll values in KRW
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in KRW
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
8.40B
9.22B
9.37B
9.28B
Cost of goods sold
4.06B
4.32B
4.56B
4.65B
Cost of revenue
4.06B
4.32B
4.56B
4.65B
Research and development expenses
166.17M
222.11M
214.66M
220.67M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.18B
2.17B
2.27B
2.16B
Operating expense
2.40B
2.34B
2.65B
2.52B
Total operating expenses
6.46B
6.66B
7.21B
7.16B
Operating income
1.94B
2.55B
2.17B
2.12B
Other non operating income
-163.55M
56.00M
-32.04M
51.95M
EBT including unusual items
1.75B
2.66B
1.80B
2.28B
EBT excluding unusual items
1.75B
2.72B
2.12B
2.28B
Income tax expense
305.20M
445.32M
256.13M
416.45M
Effective tax rate
17.41%
16.74%
14.22%
18.29%
Other operating expenses
15.75M
10.90M
15.81M
7.64M
Net income
1.60B
2.18B
1.59B
1.67B
Net profit margin
19.11%
23.63%
16.96%
17.99%
Earnings per share
-
-
-
-
Interest and investment income
66.36M
71.70M
67.38M
59.37M
Interest expense
-11.06M
-9.80M
-7.37M
-14.68M
Net interest expenses
55.30M
61.91M
60.02M
44.69M
Depreciation and amortization charges
108.11M
103.79M
109.68M
145.33M
EBITDA
2.31B
2.92B
2.54B
2.52B
Gain or loss from assets sale
-
59.48M
64.99M
1.14M
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer